Browse > Article

Clinical Review of Totally Implantable Venous Catheter  

Kim, Jung-Tae (Department of Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine)
Oh, Tae-Yoon (Department of Thoracic and Cardiovascular Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University College of Medicine)
Publication Information
Journal of Chest Surgery / v.40, no.10, 2007 , pp. 691-695 More about this Journal
Abstract
Background: The introduction of central venous catheters in 1979 has aided the administration of chemotherapy to oncologic patients. We analyzed the clinical reviews and complications of totally implantable venous catheters in an effort to achieve optimal management. Material and Method: We retrospectively studied 100 cases with totally implantable venous catheter at our hospital and we report the results. Result: 100 totally implantable venous catheters were placed in the right subclavian vein in 74 cases (74%), the left subclavian vein in 21 cases, the right jugular vein in 3 cases, the left jugular vein in 1 case and the right femoral vein in 1 case. The immediate complications were 5 cases in malposition of the catheter and 5 cases of arterial puncture. The late complications were 1 case of subclavian vein thrombosis, which was treated with anticoagulation, and 2 cases of pinch-of syndrome. There were no other early or late complications. Conclusion: The low rate of complications in this study confirms the safety and convenience of using totally implantable venous catheter in patients undergoing prolonged chemotherapy. Yet because Infection, thrombosis, and catheter fracture are the most common long term complications of totally implantable venous catheters, early diagnosis and management of these problems can prevent severe complications.
Keywords
Complication; Catheter; Chemotherapy; Cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Koch HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access system: experience in 1500 patients with totally implanted central venous port systems. World J Surg 1998:22;12-6   DOI   ScienceOn
2 Aitken DR, Catalano R, Minton JP. Central vein access in oncology patients: the 'peel-away' sheath for rapid insertion. J Surg Oncol 1983;22:81-3   DOI   ScienceOn
3 Salzman MB, Rubin LG. Intravenous catheter related infections. Adv Pediatr Infect Dis 1995;10:337-42   PUBMED
4 Vlasveld LT, Rodenhuis S, Rutgers EJTh, et al. Catheter related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter. Eur J Surg Onco 1994;20:122-9
5 Raad II, Luna M, Khalil SM, Costerton JW, Lam C, Bodey GP. The relationship between thrombotic and infectious complications of central venous catheters. JAMA 1994;271:1014-6   DOI
6 Bern MM, Lokich JJ, Wallach SR. Very low doses of wafarin can prevent thrombosis in central venous catheters: a randomized prospective trial. Ann Intern Med 1990;112:423-7   DOI   PUBMED   ScienceOn
7 Sariego J, Bootorabi B, Matsumoto T, Kerstein M. Major long term complications in 1,422 permanent venous access devices. Am J Surg 1993;165:249-51   DOI   ScienceOn
8 Barrios CH, Zuke JE, BlaesB, Hirsch JD, Lyss AP. Evaluation of an implantable venous access system in a general oncology population. Oncology 1992;49:474-8   DOI   ScienceOn
9 Ballarini C, Ceretti AP, Cordovana A, et al. Complications of subcutaneous infusion port in the general oncology population. Oncology 1999;56:97-102   DOI   ScienceOn
10 Brothers TE, Von Moll LK, Niederhuber JE, Roberts JA, Walker-Andrew S, Ensminger WD. Experience with subcutaneous infusion ports in three hundred patients. Surg Gynecol Obstet 1988;166:295-301   PUBMED
11 Hinke DH, Zandt-Stastny DA, Goodman LR, et al. Pinch-off syndrome: a complication of implantable subclavian venous access devices. Radiology 1990;177:353-6   DOI   PUBMED